Promise Bio is using broad epiproteomics and AI to advance precision medicine for chronic diseases. Our platform provides comprehensive post-translational modification (PTM) profiling enhanced with clinical and functional context, delivering insights for precise, data-driven decisions. We partner with leading research organizations and pharmaceutical companies to discover novel biomarkers, treatment selection tools, and drug targets.
Company Details
- Employees
- 14
- Founded
- 2023
- Address
- New York, Ny, Us
- Industry
- Biotechnology
- Website
- https://www.promise.bio
- Keywords
- Epiproteomics, Proteomics, Immunology, Precision Medicine, Machine Learning, Biomarkers, Diagnostics, Chronic Diseases, Autoimmune Diseases, Inflammatory Diseases, PTMs, Post-translational modifications.
- HQ
- New York, NY
Promise Bio Questions
Promise Bio's website is https://www.promise.bio
Promise Bio's LinkedIn profile is https://www.linkedin.com/company/promise-bio
Promise Bio has
14 employees.
View email and phone details for 14
employees at Promise Bio.
Promise Bio's industry is
Biotechnology
Promise Bio's top competitors are
Veracyte Inc. | C2i Genomics,
Immunai,
Aion Labs,
Combinable.ai,
Aidoc,
Neurokaire (Formerly Genetika+),
Coltac Therapeutics,
Cytoreason,
Converge Bio,
Denovai Biotech.
Promise Bio's categories are Biotechnology
Promise Bio's founding year is 2023
